4//SEC Filing
KABAKOFF DAVID S 4
Accession 0000905148-25-002244
CIK 0001661059other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:31 PM ET
Size
5.2 KB
Accession
0000905148-25-002244
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
KABAKOFF DAVID S
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+28,050→ 28,050 totalExercise: $0.47Exp: 2035-06-19→ Common Stock (28,050 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024008
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:31 PM ET
- Size
- 5.2 KB